NEW YORK (GenomeWeb News) – An international trio of European science institutes have begun a cancer research collaboration that will marshal genomics and proteomics research resources in concert with radiotherapy tools and preclinical evaluation technology to develop cancer treatments and reduce treatment side effects.
The centers involved in the effort include the Netherlands Cancer Institute (NKI) in Amsterdam, the Institut Gustave Roussy, in Paris, and Stockholm’s Karolinska Institute, NKI said on Tuesday.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.